XML 23 R6.htm IDEA: XBRL DOCUMENT v3.26.3
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity (Deficit)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non- Controlling Class B Units
Series 4 Convertible Preferred Stock
Preferred Stock
Series 5 Convertible Preferred Stock
Preferred Stock
Series 9 Convertible Preferred Stock
Preferred Stock
Series 10 Convertible Preferred Stock
Preferred Stock
Beginning Balance (in shares) at Dec. 31, 2024     1,685,021,000         1,000 126,000 1,331,000  
Beginning Balance at Dec. 31, 2024 $ 6,574   $ 2 $ 99,425 $ (622) $ (93,562)   $ 0 $ 0 $ 1,331  
Stock-based compensation – Options 455     455              
Common shares issued for net cash proceeds of ATM offering (in shares)     169,299,000                
Common shares issued for net cash proceeds of ATM offering 1,667     1,667              
Common shares issued for net cash proceeds of public offerings (in shares)     2,219,746,000                
Common shares issued for net cash proceeds of public offerings 17,902   $ 2 17,900              
Common shares issued for conversion of debt (in shares)     240,229,000                
Common shares issued for conversion of debt 750     750              
Common shares issued for exercise of liability classified warrants (in shares)     300,000,000                
Common shares issued for exercise of liability classified warrants 408     408              
Redemption of Series 9 preferred stock (in shares)                   (1,331,000)  
Redemption of Series 9 preferred stock (1,427)     (96)           $ (1,331)  
Cumulative translation adjustment 467       467            
Other (in shares)     173,245,000                
Other 5   $ 1 4              
Net (loss) income attributable to parent (12,872)         (12,872)          
Ending Balance (in shares) at Mar. 31, 2025     4,787,540,000         1,000 126,000 0  
Ending Balance at Mar. 31, 2025 13,929   $ 5 120,513 (155) (106,434)   $ 0 $ 0 $ 0  
Beginning Balance (in shares) at Dec. 31, 2024     1,685,021,000         1,000 126,000 1,331,000  
Beginning Balance at Dec. 31, 2024 6,574   $ 2 99,425 (622) (93,562)   $ 0 $ 0 $ 1,331  
Net (loss) income attributable to parent (47,176)                    
Net income attributable to noncontrolling interest 0                    
Ending Balance (in shares) at Sep. 30, 2025     30,861,816,000         1,000 126,000 0  
Ending Balance at Sep. 30, 2025 10,454   $ 31 150,263 898 (140,738)   $ 0 $ 0 $ 0  
Beginning Balance (in shares) at Mar. 31, 2025     4,787,540,000         1,000 126,000 0  
Beginning Balance at Mar. 31, 2025 13,929   $ 5 120,513 (155) (106,434)   $ 0 $ 0 $ 0  
Stock-based compensation – Options 722     722              
Common shares issued for net cash proceeds of public offerings (in shares)     6,231,200,000                
Common shares issued for net cash proceeds of public offerings (451)   $ 6 (457)              
Common shares issued for exercise of liability classified warrants (in shares)     6,771,600,000                
Common shares issued for exercise of liability classified warrants 18,009   $ 7 18,002              
Stock-based compensation (in shares)     125,000,000                
Cumulative translation adjustment 1,039       1,039            
Other 15     15              
Net (loss) income attributable to parent (20,858)         (20,858)          
Ending Balance (in shares) at Jun. 30, 2025     17,915,340,000         1,000 126,000 0  
Ending Balance at Jun. 30, 2025 12,405   $ 18 138,795 884 (127,292)   $ 0 $ 0 $ 0  
Stock-based compensation – Options 6,350     6,350              
Common shares issued for net cash proceeds of public offerings (in shares)     11,946,000,000                
Common shares issued for net cash proceeds of public offerings 3,133   $ 12 3,121              
Common shares issued for exercise of liability classified warrants (in shares)     966,976,000                
Common shares issued for exercise of liability classified warrants 1,998   $ 1 1,997              
Stock-based compensation (in shares)     33,500,000                
Cumulative translation adjustment 14       14            
Net (loss) income attributable to parent (13,446)         (13,446)          
Net income attributable to noncontrolling interest 0                    
Ending Balance (in shares) at Sep. 30, 2025     30,861,816,000         1,000 126,000 0  
Ending Balance at Sep. 30, 2025 10,454   $ 31 150,263 898 (140,738)   $ 0 $ 0 $ 0  
Beginning Balance (in shares) at Dec. 31, 2025     32,786,816         1 126 0 25,000
Beginning Balance at Dec. 31, 2025 27,743 $ 17,738 $ 33 157,354 881 (162,323) $ 10,005 $ 0 $ 0 $ 0 $ 21,793
Common shares issued in exchange of Series 10 Preferred Stock (in shares)     1,721,980               (25,000)
Conversion of Series 10 Preferred Stock to common shares and pre-funded warrants (23,737) (23,737) $ 1 (1,945)             $ (21,793)
Stock-based compensation – Options 4,847 4,847   4,847              
Common shares issued for exercise of liability classified warrants (in shares)     3,963,408                
Common shares issued for exercise of liability classified warrants 10,738 10,738 $ 4 10,734              
Series 10 Convertible Preferred Stock dividend accrual (42) (42)   (42)              
Disposition of the Inpixon Business (Note 17) (881) (881)     (881)            
Net (loss) income attributable to parent (35,270) (35,270)       (35,270)          
Net income attributable to noncontrolling interest 272           272        
Ending Balance (in shares) at Mar. 31, 2026     38,472,204         1 126 0 0
Ending Balance at Mar. 31, 2026 (16,330) (26,607) $ 38 170,948 0 (197,593) 10,277 $ 0 $ 0 $ 0 $ 0
Beginning Balance (in shares) at Dec. 31, 2025     32,786,816         1 126 0 25,000
Beginning Balance at Dec. 31, 2025 $ 27,743 17,738 $ 33 157,354 881 (162,323) 10,005 $ 0 $ 0 $ 0 $ 21,793
Stock option exercise (in shares) 37,500                    
Net (loss) income attributable to parent $ (12,022)                    
Net income attributable to noncontrolling interest 1,149                    
Ending Balance (in shares) at Sep. 30, 2026     38,477,789         1 126 0 0
Ending Balance at Sep. 30, 2026 16,985 5,831 $ 38 180,138 0 (174,345) 11,154 $ 0 $ 0 $ 0 $ 0
Beginning Balance (in shares) at Mar. 31, 2026     38,472,204         1 126 0 0
Beginning Balance at Mar. 31, 2026 (16,330) (26,607) $ 38 170,948 0 (197,593) 10,277 $ 0 $ 0 $ 0 $ 0
Stock-based compensation – Options 3,772 3,772   3,772              
Stock option exercise (in shares)     5,585                
Net (loss) income attributable to parent (2,754) (2,754)       (2,754)          
Net income attributable to noncontrolling interest 304           304        
Ending Balance (in shares) at Jun. 30, 2026     38,477,789         1 126 0 0
Ending Balance at Jun. 30, 2026 (15,008) (25,589) $ 38 174,720 0 (200,347) 10,581 $ 0 $ 0 $ 0 $ 0
Stock-based compensation – Options 5,418 5,418   5,418              
Net (loss) income attributable to parent 26,002 26,002       26,002          
Net income attributable to noncontrolling interest 573           573        
Ending Balance (in shares) at Sep. 30, 2026     38,477,789         1 126 0 0
Ending Balance at Sep. 30, 2026 $ 16,985 $ 5,831 $ 38 $ 180,138 $ 0 $ (174,345) $ 11,154 $ 0 $ 0 $ 0 $ 0